vs

Side-by-side financial comparison of Burford Capital Ltd (BUR) and PRECISION BIOSCIENCES INC (DTIL). Click either name above to swap in a different company.

PRECISION BIOSCIENCES INC is the larger business by last-quarter revenue ($34.2M vs $33.4M, roughly 1.0× Burford Capital Ltd). PRECISION BIOSCIENCES INC runs the higher net margin — 58.9% vs -112.2%, a 171.1% gap on every dollar of revenue. PRECISION BIOSCIENCES INC produced more free cash flow last quarter ($-11.3M vs $-29.3M).

Burford Capital is a financial services company that provides specialized finance to the legal market. Founded in 2009, it offers financing to corporate legal departments and law firms engaged in litigation and arbitration, asset recovery and other legal finance and advisory activities. It operates internationally with headquarters in Guernsey.

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

BUR vs DTIL — Head-to-Head

Bigger by revenue
DTIL
DTIL
1.0× larger
DTIL
$34.2M
$33.4M
BUR
Higher net margin
DTIL
DTIL
171.1% more per $
DTIL
58.9%
-112.2%
BUR
More free cash flow
DTIL
DTIL
$18.0M more FCF
DTIL
$-11.3M
$-29.3M
BUR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BUR
BUR
DTIL
DTIL
Revenue
$33.4M
$34.2M
Net Profit
$-37.5M
$20.1M
Gross Margin
Operating Margin
-37.9%
36.6%
Net Margin
-112.2%
58.9%
Revenue YoY
5261.1%
Net Profit YoY
213.5%
EPS (diluted)
$-0.16
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BUR
BUR
DTIL
DTIL
Q4 25
$33.4M
$34.2M
Q3 25
$69.8M
$13.0K
Q2 25
$191.3M
$18.0K
Q1 25
$118.9M
$29.0K
Q4 24
$638.0K
Q3 24
$159.7M
$576.0K
Q2 24
$44.3M
$49.9M
Q1 24
$17.6M
Net Profit
BUR
BUR
DTIL
DTIL
Q4 25
$-37.5M
$20.1M
Q3 25
$-19.2M
$-21.8M
Q2 25
$88.3M
$-23.5M
Q1 25
$30.9M
$-20.6M
Q4 24
Q3 24
$53.7M
$-16.4M
Q2 24
$-29.9M
$32.7M
Q1 24
$8.6M
Operating Margin
BUR
BUR
DTIL
DTIL
Q4 25
-37.9%
36.6%
Q3 25
35.5%
-158976.9%
Q2 25
74.3%
-121538.9%
Q1 25
65.4%
-76248.3%
Q4 24
Q3 24
76.1%
-3693.6%
Q2 24
32.0%
48.4%
Q1 24
-23.8%
Net Margin
BUR
BUR
DTIL
DTIL
Q4 25
-112.2%
58.9%
Q3 25
-27.4%
-167476.9%
Q2 25
46.2%
-130666.7%
Q1 25
26.0%
-70913.8%
Q4 24
Q3 24
33.7%
-2851.6%
Q2 24
-67.6%
65.6%
Q1 24
48.8%
EPS (diluted)
BUR
BUR
DTIL
DTIL
Q4 25
$-0.16
$2.62
Q3 25
$-0.09
$-1.84
Q2 25
$0.39
$-2.13
Q1 25
$0.14
$-2.21
Q4 24
Q3 24
$0.24
$-2.25
Q2 24
$-0.14
$4.67
Q1 24
$1.70

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BUR
BUR
DTIL
DTIL
Cash + ST InvestmentsLiquidity on hand
$943.5M
$115.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$2.4B
$92.2M
Total Assets
$6.6B
$154.4M
Debt / EquityLower = less leverage
0.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BUR
BUR
DTIL
DTIL
Q4 25
$943.5M
$115.6M
Q3 25
$677.7M
$44.9M
Q2 25
$372.2M
$62.2M
Q1 25
$486.6M
$77.2M
Q4 24
$86.3M
Q3 24
$101.2M
Q2 24
$123.6M
Q1 24
$137.8M
Total Debt
BUR
BUR
DTIL
DTIL
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$1.8B
Q1 25
$1.8B
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BUR
BUR
DTIL
DTIL
Q4 25
$2.4B
$92.2M
Q3 25
$2.5B
$16.6M
Q2 25
$2.5B
$34.1M
Q1 25
$2.4B
$49.3M
Q4 24
$56.4M
Q3 24
$3.2B
$64.9M
Q2 24
$3.1B
$74.7M
Q1 24
$37.2M
Total Assets
BUR
BUR
DTIL
DTIL
Q4 25
$6.6B
$154.4M
Q3 25
$6.7B
$93.5M
Q2 25
$6.3B
$108.9M
Q1 25
$6.2B
$124.4M
Q4 24
$136.4M
Q3 24
$153.3M
Q2 24
$165.8M
Q1 24
$184.7M
Debt / Equity
BUR
BUR
DTIL
DTIL
Q4 25
0.87×
Q3 25
0.86×
Q2 25
0.71×
Q1 25
0.72×
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BUR
BUR
DTIL
DTIL
Operating Cash FlowLast quarter
$-29.0M
$-11.3M
Free Cash FlowOCF − Capex
$-29.3M
$-11.3M
FCF MarginFCF / Revenue
-87.7%
-32.9%
Capex IntensityCapex / Revenue
0.8%
0.1%
Cash ConversionOCF / Net Profit
-0.56×
TTM Free Cash FlowTrailing 4 quarters
$21.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BUR
BUR
DTIL
DTIL
Q4 25
$-29.0M
$-11.3M
Q3 25
$-20.1M
$-15.3M
Q2 25
$-84.2M
$-20.3M
Q1 25
$155.2M
$-19.1M
Q4 24
$-58.4M
Q3 24
$-97.4M
$-5.9M
Q2 24
$53.0M
$-14.9M
Q1 24
$-19.0M
Free Cash Flow
BUR
BUR
DTIL
DTIL
Q4 25
$-29.3M
$-11.3M
Q3 25
$-20.1M
Q2 25
$-84.3M
$-20.3M
Q1 25
$155.1M
$-19.1M
Q4 24
$-58.7M
Q3 24
$-97.4M
$-6.0M
Q2 24
$52.9M
$-14.9M
Q1 24
$-19.1M
FCF Margin
BUR
BUR
DTIL
DTIL
Q4 25
-87.7%
-32.9%
Q3 25
-28.8%
Q2 25
-44.1%
-112627.8%
Q1 25
130.5%
-65917.2%
Q4 24
-9199.8%
Q3 24
-61.0%
-1033.2%
Q2 24
119.5%
-29.9%
Q1 24
-108.4%
Capex Intensity
BUR
BUR
DTIL
DTIL
Q4 25
0.8%
0.1%
Q3 25
0.1%
0.0%
Q2 25
0.1%
11.1%
Q1 25
0.0%
220.7%
Q4 24
39.2%
Q3 24
0.0%
6.8%
Q2 24
0.1%
0.1%
Q1 24
0.5%
Cash Conversion
BUR
BUR
DTIL
DTIL
Q4 25
-0.56×
Q3 25
Q2 25
-0.95×
Q1 25
5.02×
Q4 24
Q3 24
-1.81×
Q2 24
-0.45×
Q1 24
-2.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BUR
BUR

Principal Finance Segment$29.1M87%
Other$3.5M10%
Management Fee Income$878.0K3%

DTIL
DTIL

Segment breakdown not available.

Related Comparisons